Jones J, Gunderson C, Wigdahl B, Nonnemacher M
Epigenetics Chromatin. 2025; 18(1):9.
PMID: 40055755
PMC: 11889793.
DOI: 10.1186/s13072-025-00573-x.
Liu Z, Jin K, Xu Z, Xu J, Su X, Li B
BMJ Oncol. 2025; 2(1):e000199.
PMID: 39886491
PMC: 11234999.
DOI: 10.1136/bmjonc-2023-000199.
Bora Yildiz C, Du J, Mohan K, Zimmer-Bensch G, Abdolahi S
Epigenomics. 2025; 17(2):125-140.
PMID: 39829063
PMC: 11792803.
DOI: 10.1080/17501911.2024.2442297.
Alawathugoda T, Sheikh M, Challagandla A, Dheen S, Emerald B, Ansari S
J Biol Chem. 2025; 301(2):108173.
PMID: 39798880
PMC: 11847741.
DOI: 10.1016/j.jbc.2025.108173.
Wozniak M, Czyz M
Ther Adv Med Oncol. 2025; 17():17588359241306026.
PMID: 39776536
PMC: 11705335.
DOI: 10.1177/17588359241306026.
Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential.
Gilardini Montani M, Benedetti R, Cirone M
Molecules. 2025; 29(24.
PMID: 39769907
PMC: 11678268.
DOI: 10.3390/molecules29245817.
The signaling landscape of insulin-like growth factor 1.
Khan M, Zugaza J, Torres Aleman I
J Biol Chem. 2024; 301(1):108047.
PMID: 39638246
PMC: 11748690.
DOI: 10.1016/j.jbc.2024.108047.
Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities.
Veglia Tranchese R, Battista S, Cerchia L, Fedele M
Biomolecules. 2024; 14(11).
PMID: 39595619
PMC: 11592303.
DOI: 10.3390/biom14111443.
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer.
Chatterjee S, Linares J, Cid-Diaz T, Duran A, Khan M, Osrodek M
Nat Commun. 2024; 15(1):9755.
PMID: 39567499
PMC: 11579030.
DOI: 10.1038/s41467-024-53874-2.
PTEN depletion reduces H3K27me3 levels to promote epithelial-to-mesenchymal transition in epithelial colorectal cancer cells.
Ghobashi A, Kimani J, Ladaika C, OHagan H
PLoS One. 2024; 19(11):e0313769.
PMID: 39561122
PMC: 11575820.
DOI: 10.1371/journal.pone.0313769.
Dual-target EZH2 inhibitor: latest advances in medicinal chemistry.
Wei L, Mei D, Hu S, Du S
Future Med Chem. 2024; 16(15):1561-1582.
PMID: 39082677
PMC: 11370917.
DOI: 10.1080/17568919.2024.2380243.
Molecular mechanisms of human overgrowth and use of in its diagnostics: chances and challenges.
Prawitt D, Eggermann T
Front Genet. 2024; 15:1382371.
PMID: 38894719
PMC: 11183334.
DOI: 10.3389/fgene.2024.1382371.
Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST.
Zheng D, Zhang Y, Yang S, Su N, Bakhoum M, Zhang G
Cell Death Discov. 2024; 10(1):246.
PMID: 38777812
PMC: 11111810.
DOI: 10.1038/s41420-024-02031-1.
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer.
Treekitkarnmongkol W, Shah V, Kai K, Katayama H, Wong J, Ladha F
Br J Cancer. 2024; 131(1):171-183.
PMID: 38760444
PMC: 11231151.
DOI: 10.1038/s41416-024-02697-5.
O-GlcNAc regulates anti-fibrotic genes in lung fibroblasts through EZH2.
Wu Q, Vang S, Zhou J, Krick S, Barnes J, Sanders Y
J Cell Mol Med. 2024; 28(7):e18191.
PMID: 38494860
PMC: 10945079.
DOI: 10.1111/jcmm.18191.
A homoeostatic switch causing glycerol-3-phosphate and phosphoethanolamine accumulation triggers senescence by rewiring lipid metabolism.
Tighanimine K, Nabuco Leva Ferreira Freitas J, Nemazanyy I, Bankole A, Benarroch-Popivker D, Brodesser S
Nat Metab. 2024; 6(2):323-342.
PMID: 38409325
PMC: 10896726.
DOI: 10.1038/s42255-023-00972-y.
A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis.
Guo P, Lim R, Rajawasam K, Trinh T, Sun H, Zhang H
Elife. 2024; 13.
PMID: 38346162
PMC: 10901513.
DOI: 10.7554/eLife.86168.
Polycomb Repressive Complex 2 in Oncology.
Guo Y, Yu Y, Wang G
Cancer Treat Res. 2023; 190:273-320.
PMID: 38113005
DOI: 10.1007/978-3-031-45654-1_9.
Regulation of EZH2 Expression by INPP4B in Normal Prostate and Primary Prostate Cancer.
Zhang M, Ceyhan Y, Mei S, Hirz T, Sykes D, Agoulnik I
Cancers (Basel). 2023; 15(22).
PMID: 38001678
PMC: 10670027.
DOI: 10.3390/cancers15225418.
Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST.
Li W, Zheng D, Zhang Y, Yang S, Su N, Bakhoum M
Res Sq. 2023; .
PMID: 37886478
PMC: 10602109.
DOI: 10.21203/rs.3.rs-3270539/v1.